Literature DB >> 1784885

Immunoglobulin isotype composition of circulating and intra-articular immune complexes in patients with inflammatory joint disease.

A D Crockard1, J M Thompson, M B Finch, T A McNeill, A L Bell, S D Roberts.   

Abstract

The immunoglobulin (Ig) heavy chain isotype composition of intra-articular and circulating immune complexes (ICs) were determined by a Raji cell flow cytometric assay in paired serum and synovial fluid samples from 15 patients with rheumatoid arthritis (RA) and 15 patients with other articular diseases (osteoarthritis, ankylosing spondylitis, gout, psoriatic arthritis, Reiter's disease). ICs were most prevalent in synovial fluid samples of patients with RA but were infrequently detected in serum and synovial fluid samples from the non-RA patients. ICs in patients with RA were heterogeneous both in the prevalence of Ig subclasses identified and in the distribution of the respective Ig isotypes within the complexes. Furthermore, differences were observed in the Ig isotype composition of ICs in paired serum and synovial fluid samples indicating that circulating ICs may not always arise simply by spill-over from articular sites. The possible mechanisms for IC formation in RA are discussed with reference to four patients who displayed features of extra-articular disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1784885     DOI: 10.1007/bf00332556

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  30 in total

Review 1.  Immune complex assays: diagnostic and clinical application.

Authors:  T M Phillips
Journal:  Crit Rev Clin Lab Sci       Date:  1989       Impact factor: 6.250

2.  Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis. Partial characterization and relationship to lowered complement levels.

Authors:  R J Winchester; V Agnello; H G Kunkel
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

Review 3.  Rheumatoid factors in immune complexes of patients with rheumatoid arthritis.

Authors:  M Mannik; F A Nardella; E H Sasso
Journal:  Springer Semin Immunopathol       Date:  1988

4.  Degradation of aggregates of activated C3 (C3b) by monocytes of patients with rheumatoid arthritis is related to vasculitis.

Authors:  A H Heurkens; F C Breedveld; C V Keur; R Brand; M R Daha
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

5.  IgA containing immune complexes in rheumatoid vasculitis and in active rheumatoid disease.

Authors:  M L Westedt; M R Daha; E de Vries; R M Valentijn; A Cats
Journal:  J Rheumatol       Date:  1985-06       Impact factor: 4.666

6.  Serum immune complexes containing IgA appear to predict erosive arthritis in a longitudinal study in rheumatoid arthritis.

Authors:  M L Westedt; M R Daha; W M Baldwin; T Stijnen; A Cats
Journal:  Ann Rheum Dis       Date:  1986-10       Impact factor: 19.103

7.  Synovial synthesis of rheumatoid factors and immune complex constituents in early arthritis.

Authors:  V Jones; P C Taylor; R K Jacoby; T B Wallington
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

8.  Immune complexes in rheumatoid arthritis sera and synovial fluids: a comparison of three methods.

Authors:  J T Halla; J E Volanakis; R E Schrohenloher
Journal:  Arthritis Rheum       Date:  1979-05

9.  Circulating immune complexes in rheumatoid arthritis: a prospective study using five immunoassays.

Authors:  W J Reynolds; S J Yoon; M Emin; K R Chapman; M H Klein
Journal:  J Rheumatol       Date:  1986-08       Impact factor: 4.666

10.  Analysis of immune complexes in synovial effusions of patients with rheumatoid arthritis.

Authors:  D Male; I M Roitt; F C Hay
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

View more
  1 in total

1.  Immunoglobulin A in Graves' orbital tissue: deoxyribonucleic acid amplification by polymerase chain reaction.

Authors:  S M McLachlan; M F Prummel; J C Jaume; B Rapoport
Journal:  J Endocrinol Invest       Date:  1994-04       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.